发明名称 TIMP3 as VEGF inhibitor
摘要 Polypeptides or proteins comprising tissue inhibitor of mettaloproteinases-3 (TIMP3) or variants of TIMP3 can be used to substantially inhibit vascular endothelial growth factor (VEGF) binding to VEGF receptor-2 (VEGFR2/KDR/Flk-1)) without substantially inhibiting VEGF binding to VEGF receptor 1 (VEGFR1/Flt-1).
申请公布号 US9498509(B2) 申请公布日期 2016.11.22
申请号 US200711653647 申请日期 2007.01.16
申请人 The Cleveland Clinic Foundation 发明人 Anand-Apte Bela
分类号 A61K38/17;C07K14/00;C07K14/47;A61K48/00;A61K38/00 主分类号 A61K38/17
代理机构 Tarolli, Sundheim, Covell & Tummino LLP 代理人 Tarolli, Sundheim, Covell & Tummino LLP
主权项 1. A method of inhibiting VEGF induced endothelial cell proliferation and/or migration in a population of VEGFR2 expressing endothelial cells in the presence of VEGF, the method comprising: administering to the VEGFR2 expressing endothelial cells a polypeptide comprising a fragment of TIMP3 that includes SEQ ID NO: 9, wherein the polypeptide is effective to inhibit endothelial cell proliferation and/or migration in the population of VEGFR2 expressing endothelial cells and wherein the polypeptide is free of metalloproteinase inhibiting activity.
地址 Cleveland OH US
您可能感兴趣的专利